Vanguard Group’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
PA
CM
MVG
CFM
ACI
CGL
ST
TM
Vanguard Group's NAUT Position: Q4 2025 in Review
Vanguard Group increased its Nautilus Biotechnolgy (NAUT) stake by 6.8% in Q4 2025, buying an estimated $273K and bringing the position to 2,598,223 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3248.
Vanguard Group first reported a position in NAUT in Q3 2021 and has held it in 18 quarters since. The position peaked at $10.8M in Q2 2023. 68 funds tracked by Wall St. Rank hold NAUT as of Q4 2025.
- Vanguard Group held 2,598,223 shares of Nautilus Biotechnolgy worth $5.07M as of Q4 2025.
- Vanguard Group bought 166,394 Nautilus Biotechnolgy shares in Q4 2025, an estimated $273K.
- Nautilus Biotechnolgy made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3248 holding.
- Vanguard Group first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 18 quarters since.
- Vanguard Group's Nautilus Biotechnolgy position peaked at $10.8M in Q2 2023.
- 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.